Choroidal Thickness Indicates Subclinical Ocular and Systemic Inflammation in Eyes with Behçet Disease without Active Inflammation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: To investigate whether subfoveal choroidal thickness, measured using enhanced depth imaging optical coherence tomography (EDI-OCT), is an indicator of subclinical ocular or systemic inflammation in eyes with Behçet disease (BD) without active ocular inflammation. Methods: A retrospective analysis was used to examine clinical features of non-uveitic patients with BD (NUBD group), patients with a previous history of Behçet uveitis in an inactive state (IUBD group), and healthy controls were evaluated from October 2014 to September 2015. Subfoveal choroidal thickness was measured using EDI-OCT. Results: The NUBD group included 46 eyes in 24 patients; the IUBD group included 16 eyes in 11 patients; and the control group included 35 eyes in 23 individuals. The mean subfoveal choroidal thicknesses differed significantly among these groups. Choroidal thickness was significantly greater in the NUBD (310.5 ± 81.0 μm) than in the IUBD (263.1 ± 56.6 μm, p = 0.013) and control (256.9 ± 67.9 μm, p = 0.002) groups. The disease activity score was significantly higher in the NUBD than in the IUBD group (p < 0.001), while the use of cyclosporine was significantly associated with choroidal thickness in eyes with NUBD (p = 0.039). Conclusions: Subfoveal choroidal thickness, as measured by EDI-OCT, may be a clinical indicator of subclinical ocular inflammation and systemic inflammation in BD patients without active ocular inflammation.
Abstract
Purpose: To investigate whether subfoveal choroidal thickness, measured using enhanced depth imaging optical coherence tomography (EDI-OCT), is an indicator of subclinical ocular or systemic inflammation in eyes with Behçet disease (BD) without active ocular inflammation. Methods: A retrospective analysis was used to examine clinical features of non-uveitic patients with BD (NUBD group), patients with a previous history of Behçet uveitis in an inactive state (IUBD group), and healthy controls were evaluated from October 2014 to September 2015. Subfoveal choroidal thickness was measured using EDI-OCT. Results: The NUBD group included 46 eyes in 24 patients; the IUBD group included 16 eyes in 11 patients; and the control group included 35 eyes in 23 individuals. The mean subfoveal choroidal thicknesses differed significantly among these groups. Choroidal thickness was significantly greater in the NUBD (310.5 ± 81.0 μm) than in the IUBD (263.1 ± 56.6 μm, p = 0.013) and control (256.9 ± 67.9 μm, p = 0.002) groups. The disease activity score was significantly higher in the NUBD than in the IUBD group (p < 0.001), while the use of cyclosporine was significantly associated with choroidal thickness in eyes with NUBD (p = 0.039). Conclusions: Subfoveal choroidal thickness, as measured by EDI-OCT, may be a clinical indicator of subclinical ocular inflammation and systemic inflammation in BD patients without active ocular inflammation.
참고문헌 (25)
- Tugal-Tutkun I, "Uveitis in Behcet disease: an analysis of 880 patients", Am J Ophthalmol, 138, pp.373~380 (2004)[DOI]
- Deuter CM, "Behcet's disease: ocular effects and treatment", Prog Retin Eye Res, 27, pp.111~136 (2008)[DOI]
- Cingu AK, "Comparison of presenting features and three-year disease course in Turkish patients with Behcet uveitis who presented in the early 1990s and the early 2000s", Ocul Immunol Inflamm, 20, pp.423~428 (2012)[DOI]
- Kazokoglu H, "Demographic and clinical features of uveitis in tertiary centers in Turkey", Ophthalmic Epidemiol, 15, pp.285~293 (2008)[DOI]
- Chung YR, "C hanges in o cular manifestations of Behcet disease in Korean patients over time: a single-center experience in the 1990s and 2000s", Ocul Immunol Inflamm, 23, pp.157~161 (2015)[DOI]
- Yoshida A, "Comparison of patients with Behcet's disease in the 1980s and 1990s", Ophthalmology, 111, pp.810~815 (2004)[DOI]
- George RK, "Ocular immunopathology of Behcet's disease", Surv Ophthalmol, 42, pp.157~162 (1997)[DOI]
- Charteris DG, "CD4+ lymphocyte involvement in ocular Behcet's disease", Autoimmunity, 12, pp.201~206 (1992)[DOI]
- Atmaca LS, "Fluorescein and indocyanine green angiography findings in Behcet's disease", Br J Ophthalmol, 87, pp.1466~1468 (2003)[DOI]
- Bouchenaki N, "Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography", Klin Monbl Augenheilkd, 219, pp.243~249 (2002)[DOI]
- Kim M, "Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes", Invest Ophthalmol Vis Sci, 54, pp.6033~6039 (2013)[DOI]
- Ishikawa S, "Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behcet's disease", Br J Ophthalmol, 98, pp.1508~1513 (2014)[DOI]
- Criteria for diagnosis of Behcet's disease, "International Study Group for BehCet's Disease", Lancet, 335, pp.1078~1080 (1990)
- Suzuki Kurokawa M, "Behcet's disease", Clin Exp Med, 4, pp.10~20 (2004)[DOI]
- Mizushima Y, "Recent research into Behcet's disease in Japan", Int J Tissue React, 10, pp.59~65 (1988)
- Jabs DA, "Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop", Am J Ophthalmol, 140, pp.509~516 (2005)[DOI]
- 최효진, "Validation and reliability of a Behcet’s Syndrome Activity Scale in Korea", The Korean Journal of Internal Medicine, 31(1), pp.170~175 (2016), 대한내과학회[DOI]
- Nickla DL, "The multifunctional choroid", Prog Retin Eye Res, 29, pp.144~168 (2010)[DOI]
- Iaccarino G, "Evaluation of posterior pole with echography a nd optical coherence tomography in patients with Behcet's disease", Ophthalmologica, 223, pp.250~255 (2009)[DOI]
- Arevalo JF, "Uveitis in Behcet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group", Am J Ophthalmol, 159, pp.177~184 (2015)[DOI]
- Grzesk E, "Cyclosporine-A, but not tacrolimus significantly increases reactivity of vascular smooth muscle cells", Pharmacol Rep, 68, pp.201~205 (2016)[DOI]
- Pandey R, "Cyclosporin a disrupts notch signaling and vascular lumen maintenance", PLoS One, 10, pp.e0119279~ (2015)[DOI]
- Akay F, "Choroidal thickness in systemic arterial hypertension", Eur J Ophthalmol, 26, pp.152~157 (2016)
- Chung YR, "Choroidal thickness in patients with central serous chorioretinopathy: Assessment of Haller and Sattler Layers", Retina, 36, pp.1652~1657 (2016)[DOI]
- Coskun E, "Enhanced depth imaging optical coherence tomography findings in Behcet disease", Ocul Immunol Inflamm, 21, pp.440~445 (2013)[DOI]